Kannabia joins “We The Patients” for a groundbreaking workshop on legal cannabis cultivation in Zurich

Kannabia Seed Company is pleased to announce its collaboration with ‘We, The Patients’. This project aims not only to inform and educate, but also to empower medical cannabis patients by providing them with direct access to reliable, evidence-based information on the therapeutic use of this plant. This collaborative approach is part of a broader effort to improve medical cannabis laws and regulations in Europe. Here we explain everything there is to know about this initiative.

‘We, The Patients’ has arisen from the need to achieve a more patient-centred approach within the medical cannabis space, all thanks to a platform that has grown from online meetings to in-person events that seek to facilitate a powerful and well-informed community of patients. Through a series of webinars and events, ‘We, The Patients’ aims to help shape an environment where patients not only receive information, but also get to share their experiences and knowledge, contributing to a virtuous cycle of learning and mutual support.

Join their highlight event in Zurich

Following the successful launch of the platform in Madrid last October, and its presentation date in Switzerland in March 2025, the next 24th May, Zurich will host the workshop “Grow Your Own – Cannabis Home Cultivation”, an event organised by We The Patients to promote legal cannabis home-growing, patient empowerment, and destigmatisation of the plant. As official sponsors, Kannabia Seed Bank is proud to support this initiative, which combines education, community, and activism.

The workshop, aimed at both beginners and experienced growers, will feature hands-on sessions on CBD cultivation, legal advice, and DIY tips. Attendees will also receive exclusive gifts, including CBD seeds, organic fertilisers, and informational materials, courtesy of the sponsors.

We The Patients stands for patient autonomy and collective solidarity. This event is a unique opportunity to connect with experts, activists, and fellow cannabis enthusiasts in a collaborative learning environment.

The organisation of the events in Switzerland also benefits from the valuable support of Medcan, the country’s most influential patient association in the field of cannabinoid therapies. Medcan not only acts as co-organiser of the “We, The Patients” events in Zurich, but also plays a key role in regulatory discussions and in promoting fair and safe access to treatment. Its experience, local presence, and patient network greatly enhance the impact of these educational gatherings, bringing institutional credibility and a deep commitment to the rights of those who need it most.

Vision and objectives of a highly commendable initiative

The vision of ‘We, The Patients’ is to create a continuous cycle of events that not only address current issues in the medical cannabis field, but also establish a sustainable platform for education and ongoing support for the patient community. This includes empowerment through knowledge, the promotion of the exchange of stories and experiences, and the development of an active and empathetic support network.

The support to ‘We, The Patients’ is pretty remarkable, especially due to the strict regulations that limit advertising and promotion of cannabis as a therapeutic option. By supporting these events, we not only show our commitment to patient education and corporate social responsibility, but we also help to highlight potential cannabis-based therapies and to create content with a wide reach both nationally and internationally.

Following the Zurich event, ‘We, The Patients’ plans another series of additional get-togethers throughout the year, each dedicated to different topics where cannabis has the potential to offer significant therapeutic solutions. We’d like to invite all those interested in understanding more about medical cannabis to participate in these educational events. Because together we can advance the understanding and acceptance of the multiple properties of this plant, offering new hope and options to patients all across Europe.

Registration and more information, here.